Building a Culture of Innovation


New ideas are fundamental if companies are to retain a competitive edge.

Criticaleye speaks to Anand Gupta, Martin Grieve, Jane Griffiths, Martin Hess, Costas Markides and Mark Wood to find out how an environment can be created where people aren't afraid to think differently. 

Share this with your Community



Contributors
Anand Gupta
Growth Partner
Tata Consultancy Services
Costas Markides
Professor of Strategy and Entrepreneurship
London Business School
Jane Griffiths
Board Mentor
Criticaleye
Mark Wood
Former SVP & Managing Director Europe, Middle East and Africa
Revlon International
Martin Grieve
Advisory Board Member
Model Britain
Martin Hess
Chair
Telefonica Tech UK&I


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

Building an AI-Ready Workforce

AI is reshaping ways of working faster than most organisations can adapt, putting talent strategy at the top of the Board agenda. Criticaleye's Anna Mitchell asks Board Leaders and CPOs with hands-on experience o...


Click here to download this insight

Driving the Next Phase of Growth at RAC

In this interview with Criticaleye Senior Editor Jacob Ambrose Willson, RAC’s CFO, Jo Baker, talks through how she has helped to steer the business through a significant transformation during the last several year...


Richard Williams, Former CHRO at Western Union: How HR Becomes a Board-Level Power Function

Richard Williams, Board Mentor at Criticaleye and former Chief Human Resources Officer (CHRO) at Western Union joins Bridgette Hall, Senior Editor at Criticaleye to explore what it takes to lead HR in a global organi...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 222




LACE Partners NatWest Group NATS Southern Water Global Payments E.ON UK Hitachi Solutions Stream Aldermore Group Mayborn Group Legal & General Rolls-Royce London Stock Exchange Group AlixPartners Lightsource bp Drax Group plc British Land GlaxoSmithKline plc